Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
152
2.330
Why?
Thyroidectomy
13
2019
101
2.130
Why?
Parathyroidectomy
8
2018
78
1.520
Why?
Thyroid Diseases
6
2019
36
1.510
Why?
Parathyroid Neoplasms
5
2015
45
1.320
Why?
Thyroid Gland
7
2017
88
1.250
Why?
Vitamin D Deficiency
5
2019
45
1.180
Why?
Adenoma
4
2017
146
1.130
Why?
Parathyroid Hormone
8
2019
220
1.110
Why?
Vitamin D
4
2015
93
1.000
Why?
Fluorodeoxyglucose F18
6
2013
199
0.910
Why?
Positron-Emission Tomography
7
2013
311
0.880
Why?
Carcinoma, Papillary
4
2017
66
0.860
Why?
Ambulatory Surgical Procedures
4
2014
56
0.850
Why?
Radiopharmaceuticals
7
2015
252
0.840
Why?
Hyperparathyroidism, Primary
4
2018
53
0.780
Why?
Hyperparathyroidism
2
2015
50
0.720
Why?
Iodine Radioisotopes
3
2015
50
0.700
Why?
Megestrol Acetate
2
2007
18
0.660
Why?
Parathyroid Diseases
2
2016
9
0.650
Why?
Bone Density Conservation Agents
2
2007
82
0.620
Why?
Nursing Homes
2
2007
128
0.610
Why?
Incidental Findings
3
2013
44
0.600
Why?
Proton Pump Inhibitors
1
2015
89
0.580
Why?
Diphosphonates
1
2015
97
0.570
Why?
Thyroglobulin
2
2013
11
0.560
Why?
Academic Medical Centers
2
2012
156
0.550
Why?
Carcinoma, Medullary
2
2010
15
0.530
Why?
Parathyroid Glands
5
2018
35
0.530
Why?
Aged
19
2017
10017
0.500
Why?
Middle Aged
25
2017
13149
0.490
Why?
Hypothyroidism
2
2011
49
0.490
Why?
Retrospective Studies
14
2019
5676
0.480
Why?
Calcitonin
2
2010
40
0.460
Why?
Postoperative Complications
5
2018
1005
0.440
Why?
Male
31
2019
27231
0.440
Why?
Carcinoma
2
2012
152
0.420
Why?
Humans
44
2019
50276
0.410
Why?
Thyroid Nodule
3
2017
35
0.400
Why?
Algorithms
1
2013
690
0.400
Why?
Weight Loss
2
2009
249
0.370
Why?
Female
29
2019
27910
0.360
Why?
Appetite Stimulants
1
2007
7
0.350
Why?
Cachexia
1
2007
24
0.340
Why?
Teriparatide
1
2007
16
0.340
Why?
Aged, 80 and over
9
2017
3496
0.320
Why?
Four-Dimensional Computed Tomography
2
2017
31
0.320
Why?
Pituitary Hormones, Anterior
1
2005
3
0.310
Why?
Hypocalcemia
2
2016
15
0.310
Why?
Phenylurea Compounds
2
2015
13
0.310
Why?
Hormones
1
2005
66
0.300
Why?
Calcium
3
2018
421
0.300
Why?
Quinolines
2
2015
42
0.300
Why?
Transcriptional Activation
1
2005
140
0.290
Why?
Pituitary Gland
1
2005
73
0.290
Why?
Osteoporosis
1
2007
185
0.290
Why?
Receptors, Estrogen
1
2005
149
0.290
Why?
Interleukin-6
1
2005
299
0.270
Why?
Biopsy, Fine-Needle
5
2011
118
0.260
Why?
Protein Kinase Inhibitors
2
2015
204
0.260
Why?
NF-kappa B
1
2005
335
0.260
Why?
Illinois
2
2013
17
0.250
Why?
Treatment Outcome
8
2015
5421
0.230
Why?
Adult
13
2017
13861
0.220
Why?
Young Adult
7
2015
4120
0.200
Why?
Gene Expression Regulation
1
2005
1117
0.200
Why?
Aging
1
2005
740
0.200
Why?
Hyperparathyroidism, Secondary
1
2019
9
0.200
Why?
Follow-Up Studies
3
2013
2357
0.190
Why?
Postoperative Period
3
2015
182
0.190
Why?
Vitamins
2
2018
52
0.180
Why?
Patient Discharge
3
2016
282
0.180
Why?
Preoperative Care
2
2018
183
0.180
Why?
Intraoperative Complications
1
2019
122
0.170
Why?
Prospective Studies
2
2013
2349
0.170
Why?
United States
5
2015
4825
0.160
Why?
Insulin Resistance
2
2009
304
0.160
Why?
Antineoplastic Agents
2
2015
1244
0.160
Why?
Reoperation
1
2018
443
0.160
Why?
Predictive Value of Tests
3
2015
1044
0.150
Why?
Incidence
2
2011
1051
0.150
Why?
Hypoparathyroidism
1
2015
8
0.150
Why?
Carcinoma, Neuroendocrine
1
2015
28
0.150
Why?
Creatinine
1
2015
161
0.150
Why?
Costs and Cost Analysis
2
2014
103
0.150
Why?
Tomography, Emission-Computed, Single-Photon
1
2015
59
0.150
Why?
Adolescent
5
2015
6596
0.150
Why?
Disease Progression
3
2015
867
0.150
Why?
Lymph Nodes
1
2017
287
0.140
Why?
Molecular Targeted Therapy
1
2015
134
0.140
Why?
Ambulatory Care
1
2016
219
0.140
Why?
Neoplasm Metastasis
2
2015
258
0.140
Why?
Hospitals, University
1
2014
93
0.130
Why?
Diagnosis, Differential
6
2018
1151
0.130
Why?
Child, Preschool
2
2013
3972
0.130
Why?
Exercise
2
2009
481
0.130
Why?
Sensitivity and Specificity
2
2013
953
0.130
Why?
Technetium
1
2012
10
0.130
Why?
Hospitals, Teaching
1
2013
66
0.130
Why?
Drug Administration Schedule
1
2013
420
0.120
Why?
Preoperative Period
1
2012
61
0.120
Why?
Outpatients
1
2013
105
0.120
Why?
Administration, Oral
1
2013
459
0.120
Why?
Radionuclide Imaging
1
2012
123
0.120
Why?
Struma Ovarii
1
2012
5
0.120
Why?
Hospital Charges
1
2012
51
0.120
Why?
Liver
2
2009
1239
0.120
Why?
Tumor Burden
1
2012
142
0.120
Why?
Cost Savings
1
2012
73
0.120
Why?
Child
3
2013
6482
0.120
Why?
Patient Compliance
1
2013
265
0.120
Why?
Clinical Competence
2
2018
430
0.120
Why?
Ovariectomy
1
2012
128
0.120
Why?
Prognosis
3
2015
2057
0.110
Why?
Chromogranin A
1
2010
7
0.110
Why?
Immunohistochemistry
2
2012
1129
0.110
Why?
Radiation Monitoring
1
2010
9
0.110
Why?
Radiosurgery
1
2011
103
0.100
Why?
Checklist
1
2010
36
0.100
Why?
Obesity
2
2009
1111
0.100
Why?
Inpatients
1
2011
176
0.100
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
6
0.100
Why?
Databases, Factual
1
2013
677
0.100
Why?
Fatal Outcome
1
2010
231
0.100
Why?
Caloric Restriction
1
2009
40
0.100
Why?
Dose-Response Relationship, Drug
1
2013
1550
0.100
Why?
Intra-Abdominal Fat
1
2009
22
0.100
Why?
Proto-Oncogene Proteins c-ret
1
2009
29
0.100
Why?
Ultrasonography
4
2015
480
0.100
Why?
General Surgery
1
2010
112
0.090
Why?
Occupational Exposure
1
2010
137
0.090
Why?
Receptors, Thyrotropin
1
2007
7
0.090
Why?
Symporters
1
2007
20
0.090
Why?
Adenoma, Oxyphilic
1
2007
17
0.090
Why?
Blastomycosis
1
2008
61
0.090
Why?
Whole Body Imaging
1
2007
26
0.090
Why?
Anorexia
1
2007
9
0.090
Why?
Adiposity
1
2009
138
0.090
Why?
Ovarian Neoplasms
1
2012
441
0.090
Why?
Calcifediol
1
2006
10
0.080
Why?
Calcium Carbonate
1
2006
11
0.080
Why?
DNA, Neoplasm
1
2007
177
0.080
Why?
Practice Management, Medical
1
2006
13
0.080
Why?
Medical Audit
1
2006
27
0.080
Why?
Drug Utilization Review
1
2006
33
0.080
Why?
Severity of Illness Index
1
2011
1063
0.080
Why?
Cross-Sectional Studies
2
2014
1468
0.080
Why?
Head
1
2006
74
0.080
Why?
Geriatrics
1
2006
49
0.080
Why?
Drug Monitoring
1
2006
90
0.080
Why?
Promoter Regions, Genetic
2
2007
534
0.080
Why?
Time Factors
3
2015
3352
0.080
Why?
Otolaryngology
1
2006
53
0.080
Why?
Body Mass Index
2
2009
676
0.080
Why?
Progesterone Congeners
1
2005
6
0.080
Why?
Neck
1
2006
112
0.080
Why?
Freezing
1
2005
13
0.080
Why?
Body Fat Distribution
1
2005
14
0.080
Why?
Proportional Hazards Models
1
2007
450
0.080
Why?
Fractures, Bone
1
2006
118
0.080
Why?
Serum
1
2005
40
0.080
Why?
Gene Expression Regulation, Neoplastic
1
2010
878
0.080
Why?
Faculty, Medical
1
2006
103
0.070
Why?
DNA Primers
1
2005
234
0.070
Why?
Arkansas
2
2014
2133
0.070
Why?
Survival Analysis
1
2007
787
0.070
Why?
HeLa Cells
1
2005
296
0.070
Why?
Reproducibility of Results
3
2017
1260
0.070
Why?
Internship and Residency
1
2010
459
0.070
Why?
Base Sequence
1
2005
719
0.070
Why?
Infant
1
2012
3499
0.070
Why?
Nuclear Proteins
1
2005
269
0.060
Why?
ROC Curve
2
2015
253
0.060
Why?
Protein Binding
1
2005
756
0.060
Why?
Intraoperative Period
2
2015
54
0.060
Why?
Patient Selection
2
2018
292
0.060
Why?
Randomized Controlled Trials as Topic
1
2005
506
0.060
Why?
Tomography, X-Ray Computed
3
2012
1235
0.050
Why?
Glucagon
2
2009
32
0.050
Why?
Thalidomide
1
2002
405
0.050
Why?
Cohort Studies
2
2015
1444
0.050
Why?
Cholecalciferol
1
2018
20
0.050
Why?
Monitoring, Intraoperative
1
2019
67
0.050
Why?
Medical History Taking
1
2018
57
0.050
Why?
Hospitals, High-Volume
1
2018
33
0.050
Why?
Lymphatic System
1
2017
17
0.040
Why?
Methylene Blue
1
2017
13
0.040
Why?
Animals, Genetically Modified
1
2017
50
0.040
Why?
Risk Factors
1
2006
3860
0.040
Why?
Pilot Projects
2
2010
766
0.040
Why?
Societies, Medical
1
2018
190
0.040
Why?
Coloring Agents
1
2017
85
0.040
Why?
Mice, Inbred Strains
1
2017
207
0.040
Why?
Proto-Oncogene Proteins B-raf
1
2017
87
0.040
Why?
Recurrence
1
2018
688
0.040
Why?
Insulin
2
2009
513
0.040
Why?
Lymphatic Metastasis
1
2017
251
0.040
Why?
Bone Density
1
2018
427
0.040
Why?
Brachial Plexus
1
2015
14
0.040
Why?
Retreatment
1
2015
54
0.040
Why?
Technetium Tc 99m Sestamibi
1
2015
26
0.040
Why?
Endocrinology
1
2015
12
0.040
Why?
Axilla
1
2015
96
0.040
Why?
Hematoma
1
2015
68
0.040
Why?
Transplantation, Autologous
1
2015
459
0.030
Why?
Neoplasm Staging
1
2015
792
0.030
Why?
Hernia, Abdominal
1
2012
6
0.030
Why?
Activating Transcription Factor 1
1
2012
19
0.030
Why?
Delayed Diagnosis
1
2012
23
0.030
Why?
Mutation
1
2017
1361
0.030
Why?
Ribs
1
2010
23
0.030
Why?
Feasibility Studies
1
2011
393
0.030
Why?
Thoracotomy
1
2010
40
0.030
Why?
Hypercalcemia
1
2010
38
0.030
Why?
Mediastinal Neoplasms
1
2010
20
0.030
Why?
Neck Dissection
1
2010
47
0.030
Why?
Gas Chromatography-Mass Spectrometry
1
2009
86
0.020
Why?
Octreotide
1
2009
17
0.020
Why?
Hospitalization
1
2014
649
0.020
Why?
Glucose Tolerance Test
1
2009
75
0.020
Why?
Prevalence
1
2012
944
0.020
Why?
Adiponectin
1
2009
74
0.020
Why?
Absorptiometry, Photon
1
2009
169
0.020
Why?
Postmenopause
1
2009
83
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
309
0.020
Why?
Eye
1
2008
36
0.020
Why?
Iodine
1
2007
11
0.020
Why?
Multiple Myeloma
1
2002
2686
0.020
Why?
Bone Neoplasms
1
2010
194
0.020
Why?
Methylation
1
2007
139
0.020
Why?
Neoplasm Recurrence, Local
1
2011
576
0.020
Why?
Overweight
1
2009
195
0.020
Why?
Current Procedural Terminology
1
2006
10
0.020
Why?
Insurance, Health, Reimbursement
1
2006
29
0.020
Why?
Body Weight
1
2009
577
0.020
Why?
Office Visits
1
2006
48
0.020
Why?
Mice
1
2017
6232
0.020
Why?
Polymerase Chain Reaction
1
2007
532
0.020
Why?
Blood Glucose
1
2009
484
0.020
Why?
Genetic Predisposition to Disease
1
2009
564
0.020
Why?
Risk Assessment
1
2010
1387
0.020
Why?
Lung
1
2008
483
0.020
Why?
Thyroid Function Tests
1
2002
27
0.020
Why?
Muscle, Skeletal
1
2009
813
0.020
Why?
Thyrotropin
1
2002
42
0.020
Why?
Animals
1
2017
14247
0.010
Why?
Clinical Trials as Topic
1
2002
483
0.010
Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description